Rights and permissions
About this article
Cite this article
Losartan: potential for “major public health impact” in the EU. Pharmacoecon. Outcomes News 461, 9 (2004). https://doi.org/10.2165/00151234-200404610-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404610-00019